Home/ Supplements/ Astragalus/ Astragalus 400 mg

Astragalus 400 mg

product on market Capsule Signature Supplements Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Astragalus 400 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
50
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Blend
800 mg

Other Ingredients

Cellulose Diatomaceous Earth
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: For adults, take two (2) capsules daily, more if needed.

Warnings & Precautions

As a reminder, discuss the supplements and medications you take with your health care providers.

Keep out of reach of children.

Formulation Notes

NO: Chemical fillers or binders, artificial coloring, artificial flavor, preservatives, yeast, corn, milk or milk derivatives, lactose, salt, sodium, soy, sugar, gluten, starch or wheat.

From a GMP Facility

Immune system support

Additional Information

Store in a dry place and avoid excessive heat

Metadata

Product Details

DSLD Entry Date2025-09-25
Product TypeBotanical
FormCapsule
DSLD ID338606
Data Updated2026-04-11
Research

Research Evidence

9
Research Sources
60
Avg Quality
5
Meta Analysis
2
Cochrane Review
1
Systematic Review
1
Rct
B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis
Meta Analysis International wound journal 2024 PubMed DOI
B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Rct BMJ supportive & palliative care 2025 PubMed DOI
B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Meta Analysis Renal failure 2025 PubMed DOI
B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 PubMed DOI
C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review
Systematic Review Metabolic brain disease 2020 PubMed DOI
C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
Meta Analysis Integrative cancer therapies 2025 PubMed DOI
C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies
Meta Analysis Complementary medicine research 2023 PubMed DOI
View all evidence for Astragalus →
Compare

Similar Products

View all Astragalus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.